4//SEC Filing
Mazzo David J 4
Accession 0001334549-24-000002
CIK 0000320017other
Filed
Jan 10, 7:00 PM ET
Accepted
Jan 11, 4:10 PM ET
Size
12.2 KB
Accession
0001334549-24-000002
Insider Transaction Report
Form 4
Mazzo David J
DirectorPresident & CEO
Transactions
- Award
Common Stock
2024-01-09+94,000→ 199,308 total - Tax Payment
Common Stock
2024-01-10$3.00/sh−3,470$10,410→ 175,792 total - Tax Payment
Common Stock
2024-01-09$3.08/sh−7,843$24,156→ 179,262 total - Tax Payment
Common Stock
2024-01-09$3.08/sh−12,203$37,585→ 187,105 total - Award
Stock Option (Right to Buy)
2024-01-09+47,000→ 47,000 totalExercise: $3.08From: 2024-01-09Exp: 2034-01-09→ Common Stock (47,000 underlying)
Footnotes (5)
- [F1]Represents 94,000 restricted stock awards granted under the Issuer's 2018 Equity Incentive Compensation Plan. The restricted stock awards vest in four equal installments, with one-fourth of the shares vesting on the date of grant and an additional one-fourth vesting on each of the first, second and third annual anniversaries of the grant date.
- [F2]Includes 115,850 unvested restricted stock.
- [F3]Shares withheld as payment of a tax liability on vesting of restricted stock.
- [F4]Includes 109,166 unvested restricted stock.
- [F5]One-fourth of the shares underlying the stock options vest immediately on the grant date, with an additional one-fourth vesting on each of the first, second and third anniversaries of the grant date.
Documents
Issuer
LISATA THERAPEUTICS, INC.
CIK 0000320017
Entity typeother
Related Parties
1- filerCIK 0001334549
Filing Metadata
- Form type
- 4
- Filed
- Jan 10, 7:00 PM ET
- Accepted
- Jan 11, 4:10 PM ET
- Size
- 12.2 KB